<DOC>
	<DOCNO>NCT00977639</DOCNO>
	<brief_summary>The pathworks tissue origin test microarray-based test goal identify tissue origin patient metastatic tumor unknown primary site .</brief_summary>
	<brief_title>Evaluation Pathwork Tissue Origin ( TOO ) Test Human Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>1 Subjects must least 18 year old . The TOO test design determine tissue origin common adult malignancy . There gender/ethnic restriction . 2 Patients diagnosis malignancy establish pathologic review H &amp; E stain tumor biopsy tumor resection without definitive determination tissue origin assess PI . Samples must obtain within three month enrollment , patient must still active evaluation tissue origin time enrollment . There limitation prior therapy time last prior therapy . 3 Ability understand willingness sign write informed consent document . 1 Patients age 18 exclude . There exclusion base gender/ethnicity . 2 There exclusion requirement due comorbid disease incurrent illness , need . 3 Pregnancy nursing participant exclude study . 4 Patients diagnosis leukemia include acute myelogenous leukemia , acute lymphocytic leukemia , hairy cell leukemia , chronic myelogenous leukemia chronic lymphocytic leukemia exclude enrollment study . The TOO test cover diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>